Pediatrics Doctors in Claremore, OK Accepting Medicare

6 Pediatrics doctors found. Showing 1 - 6

Dr. William Whitley Barnes Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 525 E Blue Starr Dr, Claremore, OK 74017 Phone: 918-341-4311    Fax: 918-341-8189

Paulette L Jordan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6200

Dr. Fernando A Fernandez-zavala, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6392    Fax: 918-342-6517

Dr. Nellie Rosa, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6391

Dr. Gary Joe Lang, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 101 S Moore Ave, Claremore, OK 74017 Phone: 918-342-6392

Dr. Pamela Ann Jarrett, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1910 S Falcon Ave, Claremore, OK 74019 Phone: 918-341-1000    Fax: 918-403-6310

News Archive

Beyoncé Cosmetology Center opened at Phoenix House Career Academy

Phoenix House, the nation's leading non-profit provider of substance abuse and prevention services, today announces the opening of the Beyoncé Cosmetology Center at the Phoenix House Career Academy. A residential treatment program with a fully equipped vocational training center on site, the Career Academy, located in Brooklyn, NY, guides students as they work toward their professional and personal goals.

EORTC, GIMEMA clinical trial results show high-dose cytarabine improves outcome in AML patients

Results of the EORTC and GIMEMA AML-12 Trial appearing in the Journal of Clinical Oncology show that high-dose cytarabine in induction treatment improves outcome of adult patients with acute myeloid leukemia.

Study demonstrates an effective way to predict labor induction

When labor is induced in pregnant women, one in five women will require an emergency cesarean section.

UCSF, Genentech partner to discover and develop drug candidates for neurodegenerative diseases

The University of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, to discover and develop drug candidates for neurodegenerative diseases.

Read more Medical News

› Verified 6 days ago